JP2022500437A5 - - Google Patents
Info
- Publication number
- JP2022500437A5 JP2022500437A5 JP2021514112A JP2021514112A JP2022500437A5 JP 2022500437 A5 JP2022500437 A5 JP 2022500437A5 JP 2021514112 A JP2021514112 A JP 2021514112A JP 2021514112 A JP2021514112 A JP 2021514112A JP 2022500437 A5 JP2022500437 A5 JP 2022500437A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hyp
- lys
- virus
- containing compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018105703 | 2018-09-14 | ||
| CNPCT/CN2018/105703 | 2018-09-14 | ||
| CN2018119072 | 2018-12-04 | ||
| CNPCT/CN2018/119072 | 2018-12-04 | ||
| PCT/CN2019/105832 WO2020052677A1 (en) | 2018-09-14 | 2019-09-14 | New conjugates of montelukast and peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500437A JP2022500437A (ja) | 2022-01-04 |
| JP2022500437A5 true JP2022500437A5 (cg-RX-API-DMAC7.html) | 2022-09-21 |
| JP7759693B2 JP7759693B2 (ja) | 2025-10-24 |
Family
ID=69777394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514112A Active JP7759693B2 (ja) | 2018-09-14 | 2019-09-14 | モンテルカストおよびペプチドの新規接合体 |
Country Status (27)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3068818A1 (en) * | 2017-07-05 | 2019-01-10 | Jiangyin Mucocare Pharmaceutical Co., Ltd | Topical formulations comprising montelukast and combinations with mussel adhesive proteins |
| EP4028409A4 (en) * | 2019-09-14 | 2023-10-11 | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | NEW PEPTIDES |
| US20240218016A1 (en) * | 2019-12-02 | 2024-07-04 | Shenzhen Institutes Of Advanced Technology | Peptides and their use in the treatment of inflammation |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| WO2021207606A1 (en) * | 2020-04-10 | 2021-10-14 | University Of Georgia Research Foundation, Inc. | Methods for treatment of coronavirus infections |
| KR102596264B1 (ko) * | 2020-11-30 | 2023-11-01 | 주식회사 바이오빛 | 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물 |
| WO2022193186A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New diagnostic and therapeutic agents |
| WO2022193185A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New conjugates |
| WO2023225107A1 (en) * | 2022-05-17 | 2023-11-23 | Emory University | Diroximel fumarate, inhalation administration methods, pharmaceutical uses and compositions |
| JP2026506026A (ja) * | 2023-02-13 | 2026-02-20 | エンリティザ(シャンハイ)ファーマシューティカル カンパニー リミテッド | 新規多機能オリゴペプチド |
| AU2024312518A1 (en) * | 2023-06-22 | 2026-01-22 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New multi-functional oligopeptides |
| CN122028898A (zh) * | 2023-10-23 | 2026-05-12 | 艾缇亚(上海)制药有限公司 | 新型短链肽及其衍生物 |
| WO2025110754A1 (ko) * | 2023-11-22 | 2025-05-30 | 한도숙 | 상처 치료 또는 피부 주름형성 억제용 조성물 |
| WO2025195444A1 (en) | 2024-03-20 | 2025-09-25 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New use of peptides derived from vasoactive intestinal peptide |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| WO2003020200A2 (en) | 2000-11-16 | 2003-03-13 | New River Pharmaceuticals Inc. | A novel pharmaceutical compound and methods of making and using same |
| EP2316468A1 (en) * | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| WO2004005309A2 (en) | 2002-07-08 | 2004-01-15 | Pliva - Istrazivacki Institut D.O.O. | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| US20050107612A1 (en) | 2002-12-30 | 2005-05-19 | Dr. Reddy's Laboratories Limited | Process for preparation of montelukast and its salts |
| KR101224235B1 (ko) * | 2003-04-11 | 2013-01-25 | 메디뮨 엘엘씨 | 재조합 il9 항체 및 그의 용도 |
| US7582297B2 (en) * | 2003-04-11 | 2009-09-01 | Medimmune, Llc | Methods of treating respiratory conditions |
| US8173840B2 (en) | 2003-07-29 | 2012-05-08 | Signature R&D Holdings, Llc | Compounds with high therapeutic index |
| JP2007510621A (ja) | 2003-07-29 | 2007-04-26 | シグニチャー アールアンドディー ホールディングス,エルエルシー. | アミノ酸プロドラッグ |
| DE602005018672D1 (de) * | 2004-10-27 | 2010-02-11 | Glaxosmithkline Zagreb | Konjugate mit entzündungshemmender aktivität |
| TW200740441A (en) * | 2005-06-17 | 2007-11-01 | Combinatorx Inc | Methods and reagents for the treatment of inflammatory disorders |
| CA2773737C (en) * | 2009-09-09 | 2021-11-16 | Pharmain Corporation | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| CN102068432A (zh) | 2011-01-11 | 2011-05-25 | 李仲昆 | 一种由他定类和白三烯拮抗剂组成的外用复方组合物 |
| WO2012112690A2 (en) * | 2011-02-16 | 2012-08-23 | Fabius Biotechnology | Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
| HK1207562A1 (en) | 2012-01-18 | 2016-02-05 | 苏州泰飞尔医药有限公司 | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions |
| EP2968309A4 (en) * | 2013-03-13 | 2016-08-31 | Inflammatory Response Res Inc | USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY |
| US20160060328A1 (en) * | 2013-10-25 | 2016-03-03 | Lpath, Inc. | Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of disease |
| JP2017526728A (ja) * | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| BR112018000953A2 (pt) | 2015-07-20 | 2018-09-11 | Bengt I. Samuelsson Institute Of Life Science Research | produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele |
| CN110945016A (zh) | 2017-05-24 | 2020-03-31 | 特拉斯福特普拉斯公司 | 用于治疗炎性疾病的肽化合物、缀合化合物及其用途 |
| CA3068818A1 (en) * | 2017-07-05 | 2019-01-10 | Jiangyin Mucocare Pharmaceutical Co., Ltd | Topical formulations comprising montelukast and combinations with mussel adhesive proteins |
| CN110139662B (zh) * | 2017-07-05 | 2022-03-18 | 江阴贝瑞森制药有限公司 | 肽的抗炎用途 |
-
2019
- 2019-09-14 HU HUE19856467A patent/HUE062848T2/hu unknown
- 2019-09-14 KR KR1020217010829A patent/KR102946621B1/ko active Active
- 2019-09-14 EP EP19856467.6A patent/EP3678705B1/en active Active
- 2019-09-14 BR BR112021004823-5A patent/BR112021004823A2/pt unknown
- 2019-09-14 JP JP2021514112A patent/JP7759693B2/ja active Active
- 2019-09-14 EP EP23176152.9A patent/EP4253404A3/en active Pending
- 2019-09-14 AU AU2019338582A patent/AU2019338582B2/en active Active
- 2019-09-14 PL PL19856467.6T patent/PL3678705T3/pl unknown
- 2019-09-14 ES ES19856467T patent/ES2956509T3/es active Active
- 2019-09-14 LT LTEPPCT/CN2019/105832T patent/LT3678705T/lt unknown
- 2019-09-14 HR HRP20230946TT patent/HRP20230946T1/hr unknown
- 2019-09-14 SM SM20230210T patent/SMT202300210T1/it unknown
- 2019-09-14 CN CN201980004399.1A patent/CN111601618A/zh active Pending
- 2019-09-14 MX MX2021002657A patent/MX2021002657A/es unknown
- 2019-09-14 SI SI201930561T patent/SI3678705T1/sl unknown
- 2019-09-14 US US16/645,355 patent/US11680082B2/en active Active
- 2019-09-14 MY MYPI2021001220A patent/MY205435A/en unknown
- 2019-09-14 PT PT198564676T patent/PT3678705T/pt unknown
- 2019-09-14 CN CN202310240501.6A patent/CN116785447B/zh active Active
- 2019-09-14 SG SG11202102119RA patent/SG11202102119RA/en unknown
- 2019-09-14 CA CA3112420A patent/CA3112420A1/en active Pending
- 2019-09-14 DK DK19856467.6T patent/DK3678705T5/da active
- 2019-09-14 RS RS20230654A patent/RS64436B1/sr unknown
- 2019-09-14 WO PCT/CN2019/105832 patent/WO2020052677A1/en not_active Ceased
- 2019-09-14 FI FIEP19856467.6T patent/FI3678705T3/fi active
- 2019-09-16 TW TW108133243A patent/TWI875712B/zh active
-
2021
- 2021-03-01 ZA ZA2021/01398A patent/ZA202101398B/en unknown
- 2021-03-11 IL IL281426A patent/IL281426A/en unknown
- 2021-03-11 SA SA521421448A patent/SA521421448B1/ar unknown
-
2023
- 2023-05-12 US US18/316,496 patent/US20230348536A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3678705T3 (fi) | Montelukastin ja peptidien konjugaatteja | |
| CN105143170B (zh) | 用于治疗肺纤维化、肝纤维化、皮肤纤维化和心脏纤维化的经取代的芳族化合物 | |
| US12612430B2 (en) | Peptides | |
| JP2021525242A5 (cg-RX-API-DMAC7.html) | ||
| JP2023503380A5 (cg-RX-API-DMAC7.html) | ||
| CN113272298B (zh) | 用于治疗呼吸系统疾病的化合物和组合物 | |
| JP2026067913A (ja) | 新規なペプチドと多糖類とのコンジュゲート | |
| WO2023169557A1 (zh) | 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用 | |
| KR20250143851A (ko) | 신규한 다기능성 올리고펩타이드 | |
| RU2021105972A (ru) | Новые конъюгаты монтелукаста и пептидов | |
| CN110753688A (zh) | 用于治疗呼吸系统疾病的化合物 | |
| JP2024506291A5 (cg-RX-API-DMAC7.html) | ||
| MD3678705T2 (ro) | Conjugați de montelukast și peptide | |
| EA038170B1 (ru) | Составы 2-(имидазол-4-ил)этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний | |
| JP2003502441A (ja) | サーファクタントタンパク質cエステル |